PL1601361T3 - Pirydylosulfonamido-pirymidyny do leczenia nefropatii cukrzycowej - Google Patents

Pirydylosulfonamido-pirymidyny do leczenia nefropatii cukrzycowej

Info

Publication number: PL1601361T3
Authority: PL; Poland
Prior art keywords: diabetic nephropathy; pyridylsulfonamido; pyrimidines; treating diabetic; zero
Prior art date: 2003-03-06

Application number

PL04716605T

Other languages

English (en)

Inventor

Jessica Mann

Original Assignee

Novartis Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-06

Filing date

2004-03-03

Publication date

2008-10-31

2004-03-03 Application filed by Novartis Pharma Ag filed Critical Novartis Pharma Ag

2008-10-31 Publication of PL1601361T3 publication Critical patent/PL1601361T3/pl

Links

208000007342 Diabetic Nephropathies Diseases 0.000 title abstract 2
208000033679 diabetic kidney disease Diseases 0.000 title abstract 2
150000003230 pyrimidines Chemical class 0.000 title 1
125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 1
229910052801 chlorine Inorganic materials 0.000 abstract 1
239000000460 chlorine Substances 0.000 abstract 1
125000001309 chloro group Chemical group Cl* 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
125000004076 pyridyl group Chemical group 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000000335 thiazolyl group Chemical group 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

PL04716605T 2003-03-06 2004-03-03 Pirydylosulfonamido-pirymidyny do leczenia nefropatii cukrzycowej PL1601361T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP03100549A EP1454625A1 (en)	2003-03-06	2003-03-06	Pyridylsulfonamidyl-pyrimidines for the treatment of diabetic nephropathies
PCT/EP2004/050242 WO2004078104A2 (en)	2003-03-06	2004-03-03	Pyridylsulfonamido pyrimidines for treating diabetic nephropathy
EP04716605A EP1601361B1 (en)	2003-03-06	2004-03-03	Pyridylsulfonamido pyrimidines for treating diabetic nephropathy

Publications (1)

Publication Number	Publication Date
PL1601361T3 true PL1601361T3 (pl)	2008-10-31

Family

ID=32799012

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04716605T PL1601361T3 (pl)	2003-03-06	2004-03-03	Pirydylosulfonamido-pirymidyny do leczenia nefropatii cukrzycowej

Country Status (26)

Country	Link
US (2)	US20060094731A1 (pl)
EP (2)	EP1454625A1 (pl)
JP (1)	JP4737686B2 (pl)
KR (1)	KR101099189B1 (pl)
CN (1)	CN100453081C (pl)
AT (1)	ATE395063T1 (pl)
AU (2)	AU2004216858B2 (pl)
BR (1)	BRPI0408082A (pl)
CA (1)	CA2517930C (pl)
CY (1)	CY1108241T1 (pl)
DE (1)	DE602004013734D1 (pl)
DK (1)	DK1601361T3 (pl)
EC (1)	ECSP056060A (pl)
ES (1)	ES2305737T3 (pl)
HR (1)	HRP20050860A2 (pl)
IL (1)	IL170626A (pl)
MX (1)	MXPA05009478A (pl)
NO (1)	NO20054148L (pl)
NZ (1)	NZ542155A (pl)
PL (1)	PL1601361T3 (pl)
PT (1)	PT1601361E (pl)
RS (1)	RS20050683A (pl)
SI (1)	SI1601361T1 (pl)
UA (1)	UA82087C2 (pl)
WO (1)	WO2004078104A2 (pl)
ZA (1)	ZA200507122B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1595880A1 (en) *	2004-05-13	2005-11-16	Speedel Pharma AG	Crystalline forms of a pyridinyl-sulfonamide and their use as endothelin receptor antagonists
JP2009507890A (ja) *	2005-09-12	2009-02-26	シュペーデル・ファルマ・アーゲー	血管移植片機能不全の予防のためのピリジルスルホンアミジル−ピリミジン類
CN102933233A (zh)	2010-06-17	2013-02-13	日东电工株式会社	肾纤维化处理剂
CN109260164A (zh) *	2018-10-07	2019-01-25	威海贯标信息科技有限公司	一种阿伏生坦片剂组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0750500A1 (en) *	1994-03-17	1997-01-02	Ciba-Geigy Ag	Treatment of diabetic nephropathy with valsartan
CA2162630C (en) *	1994-11-25	2007-05-01	Volker Breu	Sulfonamides
EP0841926B1 (en) *	1995-08-02	2003-03-26	Smithkline Beecham Corporation	Endothelin receptor antagonists
US6417360B1 (en) *	1999-03-03	2002-07-09	Hoffmann-La Roche Inc.	Heterocyclic sulfonamides
AU2001263850A1 (en) *	2000-04-20	2001-11-07	Actelion Pharmaceuticals Ltd	Pyrimidine-sulfonamides having endothelin-antagonist activity

2003
- 2003-03-06 EP EP03100549A patent/EP1454625A1/en not_active Withdrawn
2004
- 2004-03-03 US US10/548,080 patent/US20060094731A1/en not_active Abandoned
- 2004-03-03 WO PCT/EP2004/050242 patent/WO2004078104A2/en not_active Ceased
- 2004-03-03 ES ES04716605T patent/ES2305737T3/es not_active Expired - Lifetime
- 2004-03-03 KR KR1020057016511A patent/KR101099189B1/ko not_active Expired - Fee Related
- 2004-03-03 UA UAA200509348A patent/UA82087C2/uk unknown
- 2004-03-03 SI SI200430798T patent/SI1601361T1/sl unknown
- 2004-03-03 HR HR20050860A patent/HRP20050860A2/hr not_active Application Discontinuation
- 2004-03-03 NZ NZ542155A patent/NZ542155A/en not_active IP Right Cessation
- 2004-03-03 JP JP2006505443A patent/JP4737686B2/ja not_active Expired - Fee Related
- 2004-03-03 CA CA2517930A patent/CA2517930C/en not_active Expired - Fee Related
- 2004-03-03 DE DE602004013734T patent/DE602004013734D1/de not_active Expired - Lifetime
- 2004-03-03 PL PL04716605T patent/PL1601361T3/pl unknown
- 2004-03-03 CN CNB2004800058469A patent/CN100453081C/zh not_active Expired - Fee Related
- 2004-03-03 PT PT04716605T patent/PT1601361E/pt unknown
- 2004-03-03 AU AU2004216858A patent/AU2004216858B2/en not_active Ceased
- 2004-03-03 DK DK04716605T patent/DK1601361T3/da active
- 2004-03-03 AT AT04716605T patent/ATE395063T1/de active
- 2004-03-03 MX MXPA05009478A patent/MXPA05009478A/es active IP Right Grant
- 2004-03-03 RS YUP-2005/0683A patent/RS20050683A/sr unknown
- 2004-03-03 BR BRPI0408082-3A patent/BRPI0408082A/pt not_active IP Right Cessation
- 2004-03-03 EP EP04716605A patent/EP1601361B1/en not_active Expired - Lifetime
2005
- 2005-09-01 IL IL170626A patent/IL170626A/en not_active IP Right Cessation
- 2005-09-05 ZA ZA200507122A patent/ZA200507122B/en unknown
- 2005-09-06 NO NO20054148A patent/NO20054148L/no not_active Application Discontinuation
- 2005-09-29 EC EC2005006060A patent/ECSP056060A/es unknown
2008
- 2008-07-28 US US12/219,751 patent/US20090005404A1/en not_active Abandoned
- 2008-08-06 CY CY20081100825T patent/CY1108241T1/el unknown
2009
- 2009-10-14 AU AU2009225323A patent/AU2009225323B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ATE395063T1 (de)	2008-05-15
CA2517930C (en)	2011-04-26
CN1756552A (zh)	2006-04-05
ECSP056060A (es)	2006-01-27
AU2004216858B2 (en)	2009-07-16
CA2517930A1 (en)	2004-09-16
HRP20050860A2 (en)	2005-10-31
NO20054148L (no)	2005-09-06
CN100453081C (zh)	2009-01-21
AU2009225323B2 (en)	2011-11-24
UA82087C2 (uk)	2008-03-11
AU2009225323A1 (en)	2009-11-05
KR20050106083A (ko)	2005-11-08
SI1601361T1 (sl)	2008-10-31
US20060094731A1 (en)	2006-05-04
DK1601361T3 (da)	2008-08-25
NZ542155A (en)	2008-09-26
US20090005404A1 (en)	2009-01-01
AU2004216858A1 (en)	2004-09-16
EP1601361B1 (en)	2008-05-14
ZA200507122B (en)	2006-05-31
JP2006519817A (ja)	2006-08-31
JP4737686B2 (ja)	2011-08-03
EP1601361A2 (en)	2005-12-07
CY1108241T1 (el)	2013-09-04
IL170626A (en)	2010-05-31
PT1601361E (pt)	2008-07-29
ES2305737T3 (es)	2008-11-01
EP1454625A1 (en)	2004-09-08
DE602004013734D1 (de)	2008-06-26
MXPA05009478A (es)	2005-10-18
WO2004078104A2 (en)	2004-09-16
KR101099189B1 (ko)	2011-12-27
RS20050683A (sr)	2007-11-15
WO2004078104A3 (en)	2004-10-28
HK1083761A1 (en)	2006-07-14
BRPI0408082A (pt)	2006-02-14

Publication	Publication Date	Title
NO20052796L (no)	2005-06-09	Indolylpyrazinonderivater anvendelige for behandling av hyper-proliferative forstyrrelser og sykdommer assosiert med angiogenese
DE60330757D1 (de)	2010-02-11	Verwendung von pyridylamiden als angiogenesehemmer
TW200505919A (en)	2005-02-16	DPP-IV inhibitors
GB0226930D0 (en)	2002-12-24	Chemical compounds
PL1940786T3 (pl)	2010-12-31	Pochodne bifenylowe i ich zastosowanie w leczeniu zapalenia wątroby typu C
ATE540928T1 (de)	2012-01-15	Isochinolinverbindungen und ihre medizinische verwendung
BR0314059A (pt)	2005-07-05	Compostos heterocìclicos
MX2007000505A (es)	2007-06-25	Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
NO20051103L (no)	2005-04-08	Indol-3-karboksamider som Glukokinase-(GK)-Aktivatorer
DK1855677T3 (da)	2009-02-09	3,11 B-CIS-dihydrotetrabanezin til behandling af skizofreni og andre psykoser
DE602004018630D1 (en)	2009-02-05	Substituierte 3-cyanothiophen acetamide als glucagon receptor antagonisten
MXPA04007391A (es)	2004-10-11	Heterociclos triciclicos fusionados utiles para el tratamiento de padecimientos hiper-proliferantes.
GB0412314D0 (en)	2004-07-07	Compounds
CY1108241T1 (el)	2013-09-04	Πυριδυλσουλφοναμιδο πυριμιδινες για την θεραπεια της διαβητικης νεφροπαθειας
DE60221813D1 (de)	2007-09-27	Thiazolopyrimidinderivate und deren verwendung als antagonisten des cx3cr1 rezeptors
BR0200536A (pt)	2003-04-29	Compostos de sulfonilpiridazinana úteis como inibidores de aldose reductase
TW200716571A (en)	2007-05-01	Heterocyclic reverse transcriptase inhibitors
IL172290A0 (en)	2006-04-10	Use of 2-amino-1-3-propanediol derivatives for the manufacture of a medicament for the treatment of various types of pain
TW200609228A (en)	2006-03-16	Substituted n-acyl-2-aminothiazoles
ZA200800999B (en)	2008-11-26	Use of N-dibenz (b,f)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy
WO2007000392A3 (en)	2007-04-05	Chloro-substituted guanidines
DK1421086T3 (da)	2006-12-11	2-(Aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl-derivater med antipsykotisk aktivitet
DK1499312T3 (da)	2007-07-02	Anvendelse af hydroxypyridonderivater til sårheling
DK1409490T3 (da)	2006-10-30	2-(Aminomethyl)tetrahydro-9-oxa-1,3-diazacyclopenta[a]-naphthalenylderivater med antipsykotisk virkning
TW200519071A (en)	2005-06-16	3-aryl-2-cyano-3-hydroxy-acrylic acid derivatives